title: Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation.
abstract: Cbl-b, a member of the Cbl family of E3 ubiquitin ligases, plays an important role in the activation of lymphocytes. However, its function in platelets remains unknown. We show that Cbl-b is expressed in human platelets along with c-Cbl, but in contrast to c-Cbl, it is not tyrosine-phosphorylated upon glycoprotein VI (GPVI) stimulation. Cbl-b, unlike c-Cbl, is not required for Syk ubiquitylation downstream of GPVI activation. Phospholipase Cgamma2 (PLCgamma2) and Bruton's tyrosine kinase (BTK) are constituently associated with Cbl-b. Cbl-b-deficient (Cbl-b(-/-)) platelets display an inhibition in the concentration-response curve for GPVI-specific agonist-induced aggregation, secretion, and Ca(2+) mobilization. A parallel inhibition is found for activation of PLCgamma2 and BTK. However, Syk activation is not affected by the absence of Cbl-b, indicating that Cbl-b acts downstream of Syk but upstream of BTK and PLCgamma2. When Cbl-b(-/-) mice were tested in the ferric chloride thrombosis model, occlusion time was increased and clot stability was reduced compared with wild type controls. These data indicate that Cbl-b plays a positive modulatory role in GPVI-dependent platelet signaling, which translates to an important regulatory role in hemostasis and thrombosis in vivo.
authors.affiliation: Department of Anatomy, Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, Pennsylvania 19140, USA. james.daniel@temple.edu
authors.forename: James L
authors.initials: JL
authors.lastname: Daniel
authors.forename: Carol A
authors.initials: CA
authors.lastname: Dangelmaier
authors.forename: Sripal
authors.initials: S
authors.lastname: Mada
authors.forename: Lorena
authors.initials: L
authors.lastname: Buitrago
authors.forename: Jianguo
authors.initials: J
authors.lastname: Jin
authors.forename: Wallace Y
authors.initials: WY
authors.lastname: Langdon
authors.forename: Alexander Y
authors.initials: AY
authors.lastname: Tsygankov
authors.forename: Satya P
authors.initials: SP
authors.lastname: Kunapuli
authors.forename: Archana
authors.initials: A
authors.lastname: Sanjay
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D000077329:Agammaglobulinaemia Tyrosine Kinase; D000818:Animals; D001792:Blood Platelets / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D051966:Phospholipase C gamma / Q000378:metabolism; D015539:Platelet Activation; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D050721:Proto-Oncogene Proteins c-cbl / Q000235:genetics / Q000378:metabolism*
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C118387:Cblb protein, mouse; D010980:Platelet Membrane Glycoproteins; C098341:platelet membrane glycoprotein VI; C492211:CBLB protein, human; D050721:Proto-Oncogene Proteins c-cbl; D011505:Protein-Tyrosine Kinases; D000077329:Agammaglobulinaemia Tyrosine Kinase; C000625949:BTK protein, human; C000625951:Btk protein, mouse; D051966:Phospholipase C gamma
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7927-32
references.pmid: 9653117
references.citation: Proc Natl Acad Sci U S A. 1989 Feb;86(4):1168-72
references.pmid: 2784003
references.citation: J Bone Miner Res. 2009 Jul;24(7):1162-72
references.pmid: 19257814
references.citation: Mol Pharmacol. 2002 Sep;62(3):672-9
references.pmid: 12181444
references.citation: Blood. 2009 Mar 12;113(11):2557-67
references.pmid: 19164598
references.citation: Thromb Res. 2005;115(1-2):95-100
references.pmid: 15567459
references.citation: J Biol Chem. 1994 Sep 16;269(37):22921-4
references.pmid: 8083187
references.citation: Biochem J. 2005 Oct 15;391(Pt 2):153-66
references.pmid: 16212556
references.citation: J Biol Chem. 1996 Feb 9;271(6):3187-94
references.pmid: 8621719
references.citation: Immunol Rev. 2005 Dec;208:106-25
references.pmid: 16313344
references.citation: Nature. 2000 Jan 13;403(6766):216-20
references.pmid: 10646609
references.citation: Immunol Today. 1998 Jun;19(6):260-4
references.pmid: 9639990
references.citation: J Biol Chem. 1998 Apr 3;273(14):8323-31
references.pmid: 9525940
references.citation: J Biol Chem. 1999 Jun 4;274(23):16619-28
references.pmid: 10347229
references.citation: Oncogene. 2001 Oct 1;20(44):6382-402
references.pmid: 11607840
references.citation: J Exp Med. 1996 Feb 1;183(2):675-80
references.pmid: 8627181
references.citation: Genes Dev. 1998 Dec 1;12(23):3663-74
references.pmid: 9851973
references.citation: Proteins. 1997 Dec;29(4):545-52
references.pmid: 9408950
references.citation: Blood. 2006 Jan 15;107(2):535-41
references.pmid: 16166583
references.citation: J Biol Chem. 1997 May 23;272(21):13576-83
references.pmid: 9153205
references.citation: Mol Cell Biol. 1998 Aug;18(8):4872-82
references.pmid: 9671496
references.citation: FEBS Lett. 2001 Sep 14;505(2):281-90
references.pmid: 11566191
references.citation: J Thromb Haemost. 2005 Aug;3(8):1752-62
references.pmid: 16102042
references.citation: Oncogene. 1996 May 2;12(9):1981-9
references.pmid: 8649859
references.citation: Biochem Biophys Res Commun. 1998 Aug 19;249(2):537-41
references.pmid: 9712732
references.citation: Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307
references.pmid: 11283727
references.citation: Mol Immunol. 2008 Feb;45(4):925-36
references.pmid: 17868870
references.citation: Blood. 2005 Jul 1;106(1):110-7
references.pmid: 15705797
references.citation: EMBO J. 2006 Feb 22;25(4):774-84
references.pmid: 16467851
references.citation: Microcirculation. 2005 Apr-May;12(3):259-74
references.pmid: 15814435
references.citation: Exp Cell Res. 2003 Sep 10;289(1):184-94
references.pmid: 12941616
references.citation: Blood. 1996 Aug 15;88(4):1330-8
references.pmid: 8695851
references.citation: Curr Biol. 1999 Feb 25;9(4):203-6
references.pmid: 10074432
references.citation: J Thromb Haemost. 2010 Jan;8(1):173-84
references.pmid: 19874458
references.citation: J Biol Chem. 1996 Oct 11;271(41):25646-56
references.pmid: 8810341
references.citation: J Leukoc Biol. 2002 May;71(5):753-63
references.pmid: 11994499
references.citation: Thromb Res. 2005;116(5):431-42
references.pmid: 16122556
references.citation: Blood. 2005 May 15;105(10):3918-24
references.pmid: 15701717
references.citation: J Thromb Haemost. 2009 Nov;7(11):1886-96
references.pmid: 19740102
references.citation: J Thromb Haemost. 2003 Nov;1(11):2419-26
references.pmid: 14629478
references.citation: Oncogene. 1997 Nov 20;15(21):2511-20
references.pmid: 9399639
references.citation: Blood. 2010 Mar 11;115(10):2008-13
references.pmid: 20065293
references.citation: J Cell Physiol. 2006 Oct;209(1):21-43
references.pmid: 16741904
references.citation: Oncogene. 1991 Apr;6(4):653-7
references.pmid: 2030914
references.citation: Nature. 2000 Jan 13;403(6766):211-6
references.pmid: 10646608
references.citation: Biochem J. 1995 Mar 1;306 ( Pt 2):337-44
references.pmid: 7534064
references.citation: Oncogene. 1995 Jun 15;10(12):2367-77
references.pmid: 7784085
references.citation: Blood. 2007 Oct 1;110(7):2449-56
references.pmid: 17579181
references.citation: J Immunol. 1999 Jun 15;162(12):7133-9
references.pmid: 10358158
references.citation: J Exp Med. 2002 Mar 18;195(6):705-17
references.pmid: 11901197
references.citation: FEBS Lett. 2004 Nov 19;577(3):555-62
references.pmid: 15556646
references.citation: J Exp Med. 2002 Jul 1;196(1):51-63
references.pmid: 12093870
references.citation: J Biol Chem. 1998 Dec 25;273(52):35273-81
references.pmid: 9857068
references.citation: J Thromb Haemost. 2007 Feb;5(2):362-8
references.pmid: 17096705
references.citation: Thromb Res. 2009 Feb;123(4):644-52
references.pmid: 18706682
references.citation: Oncogene. 1999 Feb 4;18(5):1147-56
references.pmid: 10022120